Literature DB >> 3382107

Oral phentolamine in nonspecific erectile insufficiency.

G Gwinup1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3382107     DOI： 10.7326/0003-4819-109-2-162

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Drugs for the treatment of impotence.

Authors:  L Garcia-Reboll; J P Mulhall; I Goldstein
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

2.  Erectile dysfunction: diagnosis and management with newer oral agents.

Authors:  C C Carson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-10

Review 3.  Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.

Authors:  Stephen L Archer; Ferrante S Gragasin; Linda Webster; Derek Bochinski; Evangelos D Michelakis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Pharmacological management of erectile dysfunction.

Authors:  F Montorsi; G Guazzoni; P Rigatti; G Pozza
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 5.  Impotence in elderly men.

Authors:  J E Morley; F E Kaiser
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

Review 6.  A risk-benefit assessment of sildenafil in the treatment of erectile dysfunction.

Authors:  D Vitezic
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

7.  Oral phentolamine mesylate in the treatment of complex regional pain syndrome.

Authors:  G J McCleane
Journal:  Ulster Med J       Date:  1996-05

Review 8.  Oral and injectable medications for the treatment of erectile dysfunction.

Authors:  C C Carson
Journal:  Curr Urol Rep       Date:  2000-12       Impact factor: 2.862

9.  Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH).

Authors:  Angelo J Cambio; Christopher P Evans
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.